Exagen, Inc. (XGN)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
May 08, 16:00
2.96
+0.01
(+0.34%)
Pre-Market: 20:00
Exagen EPS Diluted (Quarterly) : -0.1982 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veracyte, Inc. | 0.353 |
| Insight Molecular Diagnostics, Inc. | -0.7159 |
| bioAffinity Technologies, Inc. | -0.8077 |
| GRAIL, Inc. | -2.293 |
| FONAR Corp. | 0.3058 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.673M |
| Revenue (Quarterly) | 16.63M |
| Total Expenses (Quarterly) | 21.30M |
| Enterprise Value | 66.40M |
| Gross Profit Margin (Quarterly) | 55.35% |
| Profit Margin (Quarterly) | -28.10% |
| Earnings Yield | -31.18% |
| Normalized Earnings Yield | -29.21 |